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IMMUNOEXPRESSION OF VEGF IN ENDOMETRIAL 
CARCINOMA AND ITS HISTOPATHOLOGICAL 
CORRELATION 
ABSTRACT 
INTRODUCTION:   
Endometrial carcinoma is the third most common malignancy of 
female genital tract. Established prognostic factors in endometrial 
carcinoma include histological grade, depth of myometrial invasion and 
extra uterine spread.   Of these Angiogenesis plays an important role in 
the uncontrolled proliferation, invasion and metastasis of carcinoma and 
VEGF is one of the most known promoters of angiogenesis. Cytoplasmic 
expression of VEGF is a measure of therapeutic significance and it 
measures the aggressiveness of malignancy. 
AIM:   
To study the spectrum of histomorphology of Endometrial 
carcinoma with special reference to immunohistochemical expression of 
VEGF in Endometrial carcinoma. 
METHODS: 
This is a prospective study undertaken for a period of one year. 
Total of 32 cases of Endometrial carcinoma were studied 
Histopathologically and the Immunoexpression of   VEGF in Endometrial 
carcinoma was correlated. 
RESULTS:   
Among   the   32   cases   Type   I Endometrial carcinoma  were 20 
cases and Type II were 12 cases. Mean age of the present study is 54.96 
years.  In   the 20 cases of Type I endometrial carcinoma 12 were of well   
differentiated   grade which showed weak or moderate in positivity to 
VEGF.  In  the  12 case of Type II  Endometrial carcinoma  8 were of  
Uterine papillary serous carcinoma , 3 were clear cell carcinoma  and 1 
was carcinosarcoma which  strongly positive to VEGF. 
CONCLUSION: 
Angiogeneic activity in Endometrial carcinoma assessed by VEGF 
expression correlated well with tumour grading and appears to play an 
important role in endometrial carcinoma angiogenesis and indicates 
prognosis of patients. 
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